- Clinical
- Regulatory
- Reimbursement
- Quality
- Distribution
See all medical device clinical consulting services.
If you plan to register a “new to market” or "high risk" medical device in Japan with few predicate devices, clinical trials may be required for your medical device.
In Japan, the MHLW enforces Ordinance No. 36, "GCP Regulation," concerning the Standards for Executing Clinical Tests on Medical Devices. Furthermore, in August, 2008, a notice was issued regarding "Necessary Scope of Clinical Investigation Data on Medical Devices." It is based on GHTF SG5 N2-R08 "Clinical Evaluation."
The main contents of this new notice are as follows:
Most of the time, the PMDA accepts the results of clinical trials conducted outside of Japan if such investigation conforms to the equivalent standard in Japan's GCP Regulation. To determine acceptability of the foreign clinical data, we can assist you in scheduling a pre-consultation meeting for clinical evaluation with the PMDA. At that time the PMDA may require additional clinical investigations to be conducted in Japan. If the PMDA requires additional clinical investigations to be conducted, Emergo Japan can assist you with contracts, protocol preparation, GCP documentation, clinical investigation document review and more.